Clinical Studies

For more information about ResApp Health-sponsored clinical studies, please contact us at clinicalstudies@resapphealth.com.au.

Paediatric Clinical Studies

SMARTCOUGH-C-2 Study (NCT03392363)

Evaluating the efficacy of the ResAppDx software application in the diagnosis of childhood acute respiratory disease.

SMARTCOUGH-C Study (NCT02973282)

Evaluating the efficacy of the ResAppDx software application in diagnosis of pneumonia and other respiratory conditions in infants and children.

Breathe-Easy Paediatric Study (ACTRN12618001521213)

Developing diagnostic tests for respiratory disease using sound measurement and machine learning techniques.

Sardjito Study

The University of Queensland led clinical proof of concept study at Sardjito Hospital, Gadjah Mada University in Indonesia.

Adult Clinical Studies

COPD Screening Pilot Study (ACTRN12620000144910)

A Pilot Study using Non-Contact Smartphone Cough Sound Recordings to Screen for Chronic Obstructive Pulmonary Disease in an Indigenous Australian Adult Population.

Breathe-Easy Adult Study (ACTRN12618001521213)

Developing diagnostic tests for respiratory disease using sound measurement and machine learning techniques.

ResApp Logo White

ResApp Health Limited
ABN 51 094 468 318
Level 12, 100 Creek St, Brisbane, QLD 4000

LEGAL
Terms of Use
Privacy Policy

ResAppDx-US is pending review of a request for De Novo classification and is not available for sale in the United States.

© 2020 ResApp Health Limited. All rights reserved. US Patent No. 10,098,569, Australian Patent No. 2013239327, Japanese Patent No. 6,435,257 and Patents Pending. ResApp Health®, the ResApp Health logo and ResAppDx® are registered trademarks of ResApp Health Limited in the United States and other countries.